Cardior Pharmaceuticals Investors

15 investors on Angel Roster list Cardior Pharmaceuticals in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in Germany, the Netherlands and Switzerland.

Investors are matched on the company name in their portfolio, so companies that share the name Cardior Pharmaceuticals can appear together.

Investors listed
15
With verified email
27%
Most common stage
Series B
Top location
Germany

Updated October 13, 2026 · How we compile this data

Top 15 Cardior Pharmaceuticals investors

The most complete profiles first. Showing 15 of 15.

  • Debbie LinVerified

    Venture Capital, Corporate Venture Capital, Investor · United States

    SeedHealth CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more

    Verified email available

  • Johannes ZanzingerVerified

    Venture Capital, Corporate Venture Capital, Investor · Germany

    Series BSeries AHealth CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more

    Verified email available

  • Martin HeideckerVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · United States

    SeedHealth CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more

    Verified email available

  • Detlev MennerichVerified

    Corporate Venture Capital · Germany

    Health CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more

    Verified email available

  • Drew Burdon

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Martijn Kleijwegt

    Venture Capital, Private Equity Firm, Investor · Netherlands

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Oliver Reuss

    Venture Capital, Corporate Venture Capital, Investor · Germany

    Series BSeries AHealth CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more

    Contact details available

  • Rudy Dekeyser

    Venture Capital, Private Equity Firm, Investor · Belgium

    Series BHealth CareHospitalsLife ScienceMobile

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Sebastian Kreuz

    Venture Capital, Corporate Venture Capital, Investor · Germany

    Series BSeries AHealth CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more

    Contact details available

  • Vincent Brichard

    Private Equity Firm, Investor · Netherlands

    SeedHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Ilka Wicke Dr.

    Corporate Venture Capital · Germany

    Health CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more

    Contact details available

  • Kiran Dallenbach

    Venture Capital, Private Equity Firm · Switzerland

    Health CareChemicalLife ScienceBiotechnology

    Portfolio: Noema Pharma, CareX SA, idiag, Activaero and 41 more

    Contact details available

  • Merijn Klaassen

    Private Equity Firm · Netherlands

    Health CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Stefan Fäs

    Venture Capital, Private Equity Firm · Switzerland

    Health CareChemicalLife ScienceBiotechnology

    Portfolio: Noema Pharma, CareX SA, idiag, Activaero and 41 more

    Contact details available

  • Simone Botti

    Venture Capital, Investor · Israel

    SeedBiotechnologyElectronic Health Records (EHR)Health and Hospital ServicesDigital Health

    Portfolio: Cardior Pharmaceuticals

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Cardior Pharmaceuticals investors are on Angel Roster?

Angel Roster lists 15 Cardior Pharmaceuticals investors. 4 of them (27%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (11), Private Equity Firms (8) and Corporate Venture Capital Firms (7). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Cardior Pharmaceuticals investors invest in?

Among those that list a stage, the most common are Series B (6), Seed (4) and Series A (3).

Where are Cardior Pharmaceuticals investors based?

Most are based in Germany (5), the Netherlands (3) and Switzerland (2).

Which companies have Cardior Pharmaceuticals investors backed?

The most-backed portfolio companies among them are Promethera Biosciences (12), ImCheck Therapeutics (12), eTheRNA immunotherapies (12), Hookipa Pharma (9) and Topas Therapeutics (9).

How do I contact Cardior Pharmaceuticals investors?

Create a free Angel Roster account to search and filter all 15, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.